| Affiliation: | 1. Department of Bioengineering and Biophysics Program, University of California, Berkeley, 648 Stanley Hall, Berkeley, CA 94720, USA;2. Physical Biosciences Division, Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, CA 94720, USA;1. Harvard School of Engineering and Applied Sciences, Cambridge, MA, United States;2. Harvard T. H. Chan School of Public Health, Boston, MA, United States;1. UNC-Chapel Hill, UNC Lineberger Cancer Center and the Department of Cell Biology and Physiology, United States;2. North Carolina State University, Department of Chemical and Biomolecular Engineering, United States;3. Howard Hughes Medical Institute, UNC-Chapel Hill, United States;1. Radboud Institute for Molecular Life Sciences, Department of Cell Biology, Post 283, PO Box 9101, 6500 HB Nijmegen, The Netherlands;2. UT MD Anderson Cancer Center, Genitourinary Medical Oncology – Research, Houston, TX, USA;3. Cancer Genomics Network Netherlands (http://www.cancergenomics.nl);1. Laboratoire de Radiobiologie Cellulaire et Moléculaire, EMR3738, Faculté de Médecine Lyon Sud, 69921 Oullins, France;2. Department of Radiotherapy, Institut de Cancérologie de la Lucien Neuwirth, St Priest en Jarez, France;3. Department of Radiotherapy, GustaveRoussy, Villejuif, France;4. Department of Radiotherapy, Centre Antoine Lacassagne, Nice, France;5. INSERM U908, Growth Factor Signalling in Breast Cancer, Functional Proteomics, University Lille 1, IFR-147, 59000 Villeneuve d’Ascq, France |
